Key Record Dates
ClinicalTrials.gov Identifier: | NCT04500548 |
---|---|
Brief Title: | Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study |
First Submitted : | August 4, 2020 |
First Submitted that Met QC Criteria : | August 4, 2020 |
First Posted : | August 5, 2020 |
Last Update Submitted that Met QC Criteria : | November 20, 2020 |
Last Update Posted : | November 23, 2020 |